Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new Revision: v3.4.2 and the previous notices about government funding and operating status have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page now displays a government funding/open status notice and shows the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdd glossary toggle and update metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0), while removing older labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).SummaryDifference0.2%

- Check64 days agoChange DetectedAdded location sections for 17 sites across Alabama, Connecticut, District of Columbia, Florida, Georgia, Louisiana, Maryland, Michigan, Missouri, New Jersey, New York, Pennsylvania, South Carolina, Tennessee, Texas, Washington, and Wisconsin. Also updated the page revision to v3.3.3.SummaryDifference2%

- Check85 days agoChange DetectedThe page now shows a revision label 'Revision: v3.3.2' replacing the previous 'Revision: v3.3.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page shows a minor revision history update: the new revision v3.3.1 was added and v3.2.0 was removed; no study content or interface changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.